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Asthma in childhood becomes a lifelong
condition for many people, and there is evi-
dence that its prevalence has increased over
the past 50 years (Ross Anderson et al.
2007). Direct and indirect severe impacts on
general health, well-being, and premature
death can lead to large costs to the health
care system for the management and treat-
ment of asthma. The role of secondhand
tobacco smoke (SHS) in asthma exacerba-
tion is well accepted [U.S. Department of
Health and Human Services (DHHS)
2006], whereas its role in childhood asthma
induction is less well understood. Several
reviews and meta-analyses have weighed the
evidence of a causal relationship between
exposure to SHS and the onset of asthma in
children [Cook and Strachan 1999; Ofﬁce of
Environmental Health Hazard Assessment
(OEHHA) 1997; Strachan and Cook 1998;
U.S. DHHS 2006; U.S. Environmental
Protection Agency (EPA) 1992].
These reviews and meta-analyses differ in
their conclusions about the sufﬁciency of evi-
dence to infer a causal relationship between
SHS exposure and asthma induction in chil-
dren. The U.S. EPA and California EPA
concluded that SHS exposure is causally asso-
ciated with an increase in the incidence of
childhood asthma (OEHHA 1997; U.S.
EPA 1992), based on studies of young chil-
dren. Strachan and Cook (1998) observed
elevated estimates of relative risk (RRs) from
studies of preschool age and equivocal RRs
from studies of older children. Their meta-
analysis, originally conducted in the mid-
1990s, was updated in the most recent
Surgeon General’s Report (SGR) on Health
Effects from Involuntary Exposure to Tobacco
Smoke (U.S. DHHS 2006). The SGR con-
cluded that the evidence is suggestive, but
not sufficient to infer a causal relationship
between SHS and the induction of childhood
asthma. The SGR’s main reason for this con-
clusion is that the small number of studies
that examined an association of SHS expo-
sure from parental smoking with asthma inci-
dence among older children (when there is
reasonable diagnostic certainty) found incon-
sistent evidence of elevated RRs.
Many additional individual epidemiologic
studies have been published since 2001 (the
cutoff of Strachan and Cook’s latest update in
the SGR) (Gilliland et al. 2001; Hessel et al.
2001; Jaakkola et al. 2001; Kivity et al. 2001;
Mannino et al. 2001; Pokharel et al. 2001;
Sturm et al. 2004; Takamura et al. 2001).
Several of these newer studies have reported
that control for important confounding vari-
ables such as atopy history (family or child
history of atopy), prenatal exposure to mater-
nal smoking, and smoking status of older
children can substantially alter RRs (Gilliland
et al. 2001; Hessel et al. 2001; Jaakkola et al.
2001; Pokharel et al. 2001). Because atopy
history was a particularly important con-
founder, we chose to conduct a meta-analysis
of studies that controlled for atopy history.
We examined the effects of other potentially
confounding factors and study-wide charac-
teristics on the summary RR of developing
childhood asthma from exposure to house-
hold SHS to see whether consistent patterns
of RRs emerge.
One of our goals was to use meta-regres-
sion on atopy-controlled studies to quantita-
tively explore the effects of these other
potentially important sources of heterogeneity
on the summary RR. Some of the heterogene-
ity among RRs reported in previous meta-
analyses (Cook and Strachan 1999; Strachan
and Cook 1998; U.S. DHHS 2006) may be
related to uncontrolled confounding factors
such as atopy history, age, sex, race, and the
status of smoking in older study subjects.
Other sources of heterogeneity among studies
may include the age at which exposure and
disease status are assessed, the assessment of
maternal smoking versus other SHS sources,
the evaluation of prenatal versus postnatal
SHS exposure, the use of asthma incidence
versus asthma prevalence as the outcome
measure, the type of study design, or the sub-
ject recruitment source.
Our systematic review considered studies
addressed in the meta-analyses of Cook and
Strachan (1999), OEHHA (1997), Strachan
and Cook (1998), and U.S. DHHS (2006).
Our meta-analysis used the power provided
by the more recent studies and the simulta-
neous examination of multiple characteristics
through meta-regression to further examine
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OBJECTIVE: Studies have identified associations between household secondhand tobacco smoke
(SHS) exposure and induction of childhood asthma. However, the true nature and strength of this
association remains confounded in many studies, producing inconsistent evidence. To look for
sources of potential bias and try to uncover consistent patterns of relative risk estimates (RRs), we
conducted a meta-analysis of studies published between 1970 and 2005.
DATA SOURCES: Through an extensive literature search, we identiﬁed 38 epidemiologic studies of
SHS exposure and the development of childhood asthma (that also controlled for atopy history)
from 300 potentially relevant articles.
DATA SYNTHESIS: We observed substantial heterogeneity within initial summary RRs of 1.48 [95%
conﬁdence interval (CI), 1.32–1.65], 1.25 (1.21–1.30), and 1.21 (1.08–1.36), for ever, current, and
incident asthma, respectively. Lack of control for type of atopy history (familial or child) and child’s
own smoking status within studies and age category altered summary RRs in separate meta-
regressions. After adjusting for these confounding characteristics, consistent patterns of association
emerged between SHS exposure and childhood asthma induction. Our summary RR of 1.33 (95%
CI, 1.14–1.56) from studies of incident asthma among older children (6–18 years of age) is 1.27
times the estimate from studies of younger children and higher than estimates reported in earlier
meta-analyses.
CONCLUSIONS: This new ﬁnding indicates that exposure duration may be a more important factor
in the induction of asthma than previously understood, and suggests that SHS could be a more
fundamental and widespread cause of childhood asthma than some previous meta-analyses have
indicated.
KEY WORDS: childhood asthma, environmental tobacco smoke, ETS, meta-analysis, meta-regression,
relative risk, secondhand tobacco smoke, SHS. Environ Health Perspect 115:1394–1400 (2007).
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induction of childhood asthma. We were
particularly interested in the relationship
between household SHS exposure and child-
hood asthma induction in older children.
Methods
Literature search. We requested a literature
search for SHS as a risk factor in the develop-
ment of childhood asthma examined in epi-
demiologic studies published between 1970
and 2005. Outcome key words included
asthma, wheezy bronchitis, asthmatic bronchi-
tis, and reactive airway disease. Exposure key
words included ETS, environmental tobacco
smoke, passive smoking, secondhand smoke,
involuntary smoke, tobacco smoke pollution,
and cigarette smoke. We limited the search to
asthma in childhood and adolescence (through
18 years of age).
A professional experienced librarian
searched PubMed (http://www.pubmed.gov),
Web of Science (http://portal.isiknowledge.
com/), Biosis Previews(http://portal.
isiknowlege.com/), Toxline (http://toxnet.
nlm.nih.gov), Sciﬁnder Scholar (http://www.
cas.org/products/sfacad/index.html),
Environmental Sciences and Pollution
Management (http://www.csa.com), Melvyl
(http://melvyl.cdlib.org), WorldCat (OCLC)
Firstsearch (http://firstsearch.oclc.org),
University of California and San Francisco
Tobacco Control Archives (http://www.
library.ucsf.edu/tobacco/). Manual searches
were conducted from review articles and pre-
vious meta-analyses. When necessary, we
contacted authors for additional information
or for translations from languages other than
English. 
Selection criteria. We developed eight cri-
teria to select studies from among peer-
reviewed articles. First, studies should present
a) outcomes of the development (not exacer-
bation) of new cases of asthma or, because of
ambiguities related to the diagnosis of asthma
in young children, wheezy bronchitis (but
not wheeze alone); we used broad criteria to
define new incident cases of asthma that
included both allergic and nonallergic
descriptions of asthma. However, we sought
to include all studies that identiﬁed cases of
asthma in their analyses by other criteria than
symptoms of wheeze alone. Our definition
included asthma, wheezy bronchitis, or
asthma/wheeze that was ever or currently rec-
ognized by doctor diagnosis or by a set of
symptoms that are recognized criteria for
diagnosing asthma in addition to wheezing.
We also included asthma identified
through parental response to pilot-tested or
standardized questionnaires on respiratory
health. Studies should also present b) compa-
rable groups of subjects (i.e., exposed and
unexposed, cases and referents selected by
the same criteria); c) at least one source of
postnatal household SHS exposure; d) ade-
quate data for extracting or calculating RRs
and their standard errors; this information
may be presented as odds or rate ratios or
estimates of relative risk; e) results for chil-
dren (0–18 years of age) where the child was
the unit of analysis; f) completed and origi-
nal work (not abstracts of work in progress
or reviews); g) reports written in languages
other than English that are commonly spo-
ken in Europe (i.e., German, Italian, French,
and Spanish); and h) studies that controlled
for the confounding effect of atopy history
because atopy has such a strong association
with asthma and parental smoking behavior.
Our control for atopy history category
included: family history of allergy or asthma;
childhood diagnosis of allergic conditions
other than asthma, such as eczema, hay fever,
or allergic rhinitis; the respondent in the
study reported symptoms of allergic condi-
tions; or the study investigator stratified on
an indicator of atopy such as skin-prick test
results. We considered the study controlled
for atopy history if the study restricted the
selection of subjects to children with, sub-
groups were stratiﬁed by, or the estimate of
RR was statistically adjusted for atopy his-
tory as defined above. We rejected studies
that did not meet these criteria. When more
than one analysis was conducted on the same
set of children, we included information
from multiple articles if they provided
unique information about the children.
Data abstraction. We extracted RRs and
standard error estimates from publications
using methods described by Greenland
(1987). Odds ratios were corrected to RRs
even though the prevalence of asthma was
often not much more than 10% in the study
population (Zhang and Yu 1998). We initially
analyzed studies from which population preva-
lence estimates were not available (i.e., from
many case–control studies), and later removed
them from the pool of available studies.
The variables we considered as potential
covariates in each meta-regression are
described in Table 1. We grouped covariates
into two subgroups and gave each covariate a
value of 0 or 1. We considered that a study
controlled for a covariable if the study
restricted the selection of subjects to children
from a single covariable category, or if the
subgroups were stratiﬁed by, or the estimate
of RR was statistically adjusted to, persons
who belong to a single category of that
covariable. We classified SHS exposure as
average (or adjusted to 15 cigarettes/day
smoked in the home). 
Data analysis. The ﬁrst two meta-analy-
ses in this review are an analysis of average
SHS exposure on RRs from studies of newly
diagnosed or persistent asthma (current
asthma), and the RR from studies of asthma
that may have occurred early in life and sub-
sequently resolved (ever asthma). In the third
meta-analysis of SHS effect on asthma inci-
dence in this review, we included studies that
examined SHS exposure effects and classiﬁed
subjects by continued exposure before the
onset of asthma.
Where possible, we collapsed exposure
levels within studies that used a common ref-
erence group and adjusted for correlations
among estimates using methods described by
Greenland and Longnecker (1992). We
adjusted exposure measures such as cotinine
levels in blood and the number of smokers in
the home or cigarettes smoked by household
occupants to be approximately equivalent to
the number of cigarettes smoked per day in
the home [see Supplemental Material,
Appendix A for the details and conversion
factors used for this adjustment (http://www.
ehponline.org/docs/2007/10155/suppl.pdf)].
Although most of the RRs in the studies
included in this review indicated a positive
association for both current and ever asthma,
there was substantial heterogeneity in the
magnitude of the SHS effect across studies.
We performed separate subanalyses for studies
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Table 1. Covariates considered in meta-regression based on outcome deﬁnition.
Meta-regression by asthma outcome
Covariate Current Ever Incident 
Geographic region Yes Yes Yes
Age category Yes Yes Yes
Type of SHS source Yes Yes No
Timing of exposure (postnatal only) Yes Yes Yes
Source of study subjects Yes Yes Yes
Type of study Yes Yes No
Not controlled for age or sex Yes No Yes
Not controlled for race Yes Yes No
Not controlled for child’s own smoking Yes Yes No
Not controlled for child history of atopy  Yes Yes Yes
Not controlled for family history of atopy  Yes Yes No
Not controlled for family and child atopy Yes  Yes No
Asthma not identiﬁed by doctor diagnosis Yes Yes Yes
“Yes” indicates that the variable was evaluated in meta-regression; “No” indicates that the variable was not evaluated in
meta-regression because no observations differed for this covariate or the variable was redundant to another variable.of current and ever asthma because we sus-
pected that differences in study design and
case detection speciﬁc to the type of asthma
studied might explain RR heterogeneity.
Within cohort studies that classiﬁed subjects
by exposure status at the start of follow-up,
we sought to examine the effect of exposure
years on incident asthma. Each analysis is
comprised of independent sets of study sub-
jects. Several studies provided separate esti-
mates of RR for both current and ever
asthma. To avoid overlapping populations
among analyses, we included only the current
asthma RR.
We estimated summary RRs using
inverse variance-weighted least-squares meth-
ods (DerSimonian and Laird 1986). If the
chi-squared statistic from the homogeneity
test was greater than its degrees of freedom,
we used a random-effects method to account
for between-study variability; otherwise, we
used a ﬁxed-effects method.
To explore the sources of RR heterogene-
ity, we modeled the log RR as a function of
predictors in a linear meta-regression model.
Each covariate was considered as a potential
modiﬁer of the RR. We included all covari-
ates for which the p-value was < 0.1.
We regarded the model as accounting for
RR heterogeneity if the homogeneity chi-
square was less than or equal to its degrees of
freedom. If our model did not account for
the heterogeneity in this sense, after consid-
ering all eligible covariates, we examined the
inﬂuence of individual studies. We detected
outliers by removing one study at a time and
estimating a weighted average estimate of all
other studies. We conducted this study inﬂu-
ence analysis using “Metainf,” a statistical
function of Stata version 8.0 (StataCorp. LP,
College Station, TX) that sequentially
removes one study at time, and then recalcu-
lated RR to determine the effect that the
removed study’s RR has on the average RR
for all studies.
We managed data using SAS version 8.2
(SAS Institute Inc., Cary, NC) and Microsoft
Office Excel 2000 ( Microsoft, Redmond,
WA) and analyzed the data using Stata
(version 8.0).
Results
Our search generated > 500 abstracts for
review, which produced 300 potentially rele-
vant articles. We received responses from six of
the eight authors we had contacted to obtain
additional information needed to determine a
study’s eligibility. Thirty-eight articles reported
at least one risk estimate that met our inclu-
sion criteria (Tables 2–4). Twelve articles
[Aberg et al. 1995; Aberkane 1998; Al-Frayh
et al. 1992; Bener et al. 1993a, 1993b;
Bergmann et al. 1998; Franklin et al. 1985;
Luttmann et al. 1993; Moussa et al. 1996;
Medical Research Council (MRC) 1966,
1986; Ronmark et al. 1999] and the Abacci
Atlas website (Shank 2000; http://www.abacci.
com/atlas/demography.asp?countryID=352)
provided information on additional character-
istics about the study design or population
associated with 10 of these studies. We
rejected 248 articles; in cases where there were
multiple reasons for exclusion, we have
reported only one (see Figure 1 for details).
We treated each of the 38 articles as an
individual study unless RRs were reported
Vork et al.
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Table 2. Descriptions of the 15 studies and 14 published articles that presented data on household SHS
exposure and current asthma for the meta-analyses.
Reference Study Study Case doctor No. of cases/
(subgroup) location design diagnosed referents RR 95% CI
Agabiti et al. 1999 (te)  Italy CC No 1,060/12,304 1.18 1.03–1.34
Agabiti et al. 1999 (gr)  Italy CC No 733/11,811 1.32 1.14–1.54
Azizi et al. 1995 Malaysia CC Yes 158/201 1.91 1.13–3.21
Chen et al. 1996 (ac)  Canada XS Yes 64/280 0.86 0.39–1.89
Daigler et al. 1991 USA CC Yes 137/246 1.96 1.10–3.47
Ehrlich et al. 1996 S. Africa CC No (a/w) 325/250 1.32 1.03–1.70
Gilliland et al. 2001 USA XS Yes 511/5,048 1.48 1.01–2.17
Mannino et al. 2001 USA XS Yes 3,629a 1.36 0.88–2.08
Murray and Morrison Canada CC Yes 163/233 0.93 0.60–1.60
1990 (ac)
Palmieri et al. 1990 (nac)  Italy CC Yes 72/433 1.47 0.98–2.21
Ronmark et al. 1998  Sweden XS No 182/3,249 1.60 1.25–1.95
Selcuk et al. 1997  Turkey XS Yes 303/5,109 1.28 0.94–1.75
Soto-Quiros et al. 1994 Costa Rica XS No 563/1,865 1.53 1.15–2.03
Sturm et al. 2004 USA XS Yes 11,378/92,730 1.24 1.19–1.29
Wolf-Ostermann et al. 1995 Germany XS Yes 4,678a 1.43 0.96–2.12
Abbreviations: ac, atopic children; a/w, asthma/wheeze; CC, case–control; gr, 6- to 7-year-old subjects; nac, nonatopic
children; RR, relative risk estimate (not corrected); te, 13- to 14-year-old subjects; XS, cross-sectional; Yes/No, doctor-
diagnosed asthma. 
aStudy total (case/reference information was not given in the article). 
Table 3. Descriptions of the 30 studies and 22 published articles that presented data on household SHS
exposure and ever asthma for the meta-analyses.
Reference Study Case doctor Cases/
(subgroup) location diagnosed referents RR 95% CI
Azizi and Henry 1991 Malaysia Yes (a/w) 206/1,295 1.1 0.9–1.4
Bener et al. 1991 Saudi Arabia Yes 235/2,806 1.77 0.80–3.91
Burchﬁel et al. 1986 (bo)  USA No  187/1,028 2.16 1.39–2.93
Chen et al. 1996 (ac)  Canada Yes 76/268a 1.39 0.60–3.21
Chen et al. 1996 (nac)  Canada Yes 17/531 5.82 1.60–21.1
Gergen et al. 1998  USA Yes 442/7,236 1.45 1.17–1.79
Gilliland et al. 2001  USA Yes 4,314a 1.1 0.9–1.4
Goren and Hellman 1991 Israel No  870/7,389 1.24 1.05–1.43
Gortmaker et al. 1982  USA No  188/2,884 1.49 1.08–2.06
Hajnal et al. 1999  Switzerland No  407/4,034 1.20 0.94–1.54
Jenkins et al. 1993  Australia No (a/w) 1,349/7,182 1.26 1.12–1.40
Kay et al. 1995 England No  73/122 1.92 1.27–2.90
Kivity et al. 2001 (Ar,bo,ac)  Israel No  38/242b 1.73 1.44–2.07
Kivity et al. 2001 (Ar,bo,nac)  Israel No 38/242b 1.74 1.12–2.69
Kivity et al. 2001 (Ar,g,ac) Israel No  27/351b 1.73 1.43–2.09
Kivity et al. 2001 (Ar,g,nac)  Israel No 27/351b 1.61 0.96–2.68
Kivity et al. 2001 (J,bo,ac)  Israel No 43/244b 1.73 1.45–2.06
Kivity et al. 2001(J,bo,nac)  Israel No 43/244b 1.74 1.22–2.50
Kivity et al. 2001 (J,g,ac)  Israel No 36/262b 1.73 1.44–2.07
Kivity et al. 2001 (J,g,nac)  Israel No 36/262b 1.75 1.14–2.69
Le Roux et al. 1995 France Yes 99/1,094 1.79 1.06–3.02
Maier et al. 1997 USA Yes 106/819 1.6 0.9–2.7
Mannino et al. 2001  USA Yes 3,629a,c 1.19 0.83–1.72
Pokharel et al. 2001 India No (a/w) 40/80d 3.33 1.85–7.65
Rasanen et al. 2000  Finland Yes 179/4,399 1.48 0.97–2.25
Ronmark et al. 1998 Sweden No  276/3,155a 1.29 0.95–1.74
Selcuk et al. 1997  Turkey Yes 888/4,524a 1.35 1.12–1.62
Soyseth et al. 1995  Norway No  51/567 2.8 1.3–6.1
Takemura et al. 2001  Japan Yes 2,315/21,513 0.95 0.87–1.03
Wolf-Ostermann et al. 1995 Germany Yes 4,678a,c 1.43 0.96–2.12
Abbreviations: ac, atopic children; ap, parents with atopy history; Ar, Arab; a/w, asthma/wheeze; bo, boys; g, girls;
J, Jewish; nac, nonatopic children; nap, parents with no atopy history; RR, relative risk estimate (not corrected); Yes/No,
doctor-diagnosed asthma.
aExcluded study already included in the current asthma analysis (see Table 5). bIncludes atopic and nonatopic group.
cStudy total (case/reference information was not given in the article). dCase–control study design (all other studies are
cross-sectional design).for more than one independent set of study
subjects. For example, because Chen et al.
(1996) reported distinct estimates for
children by atopic history, this study was
subdivided into two studies. This process
produced 53 studies total. Of these, 32 were
cross-sectional, 13 were case–control, and 8
were cohort designs.
Study methodologies and key characteris-
tics. Tables 2–4 describe the 53 studies meet-
ing the eight criteria that we have included
in our meta-analyses. These studies include
approximately 200,000 children and adoles-
cents (≤ 18 years of age) from 20 countries.
Study design. About half of the studies
that examined average household SHS expo-
sure and current asthma were case–control
and half were cross-sectional design. Studies
ranged from < 200 to > 100,000 study sub-
jects. All but one of the studies that exam-
ined average household SHS exposure and
ever asthma were cross-sectional. Among the
cohort studies, populations ranged from
< 200 to nearly 15,000 subjects.
Summary RR using different exposure ref-
erence groups. The summary or weighted aver-
age of RRs, tests for RR heterogeneity, and
RR percentiles are shown in Table 5 for each
meta-regression. Before combining estimates
of RR, we applied a correction factor to odds
ratios and removed ﬁve studies (four current
asthma, one ever asthma) that did not provide
an estimate of prevalence. Among studies of
current asthma, a homogeneous (p = 0.528)
combined estimate of RR emerged. The
observations we included in our corrected
analyses are included in online tables
(Supplemental Material, available online at
http://www.ehponline.org/docs/2007/10155/
suppl.pdf). Substantial heterogeneity among
cross-sectional studies was observed in the ever
asthma group when the reference group was
no household exposure, and among the inci-
dent asthma group when the reference group
was no maternal smoking exposure. Results
are presented from random-effects models.
RRs tended to be similar in eight cohort studies
for which the SHS exposure was assessed before
the onset of asthma [summary RR = 1.21; 95%
conﬁdence interval (CI), 1.08–1.36; RR range,
0.84–1.49] to 11 case–control studies or cross-
sectional studies of average household SHS
exposure and current asthma where exposure
to SHS was assessed at the time of diagnosis or
case identification (summary RR = 1.25;
95% CI, 1.21–1.30; RR range, 0.86–2.17).
The summary RRs among prevalence studies
was higher among 23 studies of ever asthma,
at 1.48 (95% CI, 1.32–1.65; RR range,
0.57–5.81) (Table 5).
Household SHS exposure and ever asthma.
The observations we included in our subgroup
analyses of average household SHS exposure
and ever asthma are summarized in Table S1
(Supplemental Material, available online at
http://www.ehponline.org/docs/2007/10155/
suppl.pdf). Substantial heterogeneity remained
(homogeneity p < 0.001) after ﬁtting a meta-
regression model that included four covariates
and for which no additional covariates entered
the model. Most of this heterogeneity
appeared to be attributed to the summary esti-
mate from one large study (Takemura et al.
2001). We treated this study as an outlier
because it used a stricter deﬁnition of asthma
to classify subjects as cases compared with the
other studies included in our database.
Classifying subjects in this way might have
resulted in a bias downward if milder cases of
asthma among children exposed to SHS were
classiﬁed as noncases. After removing this out-
lier study, three covariates then accounted for
heterogeneity in the meta-regression model:
studies that were not a) controlled for family
history of atopy, b) restricted to nonsmoking
children, c) restricted to children of school age
(Table 6).
The strongest modifier of the ever
asthma summary RR was lack of control for
a child’s own smoking habits. The study
summary RRs from studies that did not con-
trol for this covariate were 1.35 times higher
than controlled studies. Lack of control for
a) family history of atopy, b) age category of
the study subjects, and c) smoking habits
among study subjects were weaker modiﬁers
for ever asthma studies [summary RRs were
0.84 and 1.20 times the joint reference esti-
mate of RR of 1.21 (95% CI, 1.17–1.26);
see Table 6 for reference categories]. This
estimate is lower than the corresponding
summary RR without adjustment for covari-
ates, 1.48 (95% CI, 1.32–1.65; Table 5).
Household SHS exposure and incident
asthma. The observations we included in our
subgroup analyses of household SHS expo-
sure and incident asthma are summarized in
online Table S2 (Supplemental Material,
available online at http://www.ehponline.
org/docs/2007/10155/suppl.pdf).
The results of the meta-regression for eight
cohort studies appear at the end of Table 6.
SHS exposure and incident asthma RR was
0.79 times higher among studies of preschool
children than among studies of school-age
children, and 0.82 times higher when studies
did not control for child atopy than for studies
that controlled for this covariable.
The predicted RR for SHS exposure
effect on incident asthma among children in
the joint reference category of all covariates
was 1.33 (95% CI, 1.14–1.56; see Table 6
for reference categories). This estimate is
higher than the corresponding summary RR
without adjustment for covariates, 1.21,
(95% CI, 1.08–1.36; Table 5).
Discussion
This meta-analysis extends previous work
by focusing on atopy-controlled studies,
which has been well established as a source of
Secondhand tobacco smoke and new childhood asthma
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Figure 1. Literature search strategy. 
Search of 11 electronic databases; also
manual search from reviews and
original study reference lists
Potentially relevant publications screened
n = 540
Articles retrieved
for detailed
review n = 300
Excluded based
on title and/or
abstract n = 240
Articles with
more data
n = 13
(related to
10 of the 38
study articles)
Excluded articles n = 248
specific reasons: no risk
estimate represented
development of asthma
or wheezy bronchitis
(n = 88), exposure not
postnatal household SHS
(n = 40), not original or
completed work (n = 31),
absent data for calculating
estimated (n = 14),
selection criteria differed
between referents and
cases (n = 14), not in
English, German, Italian,
or French (n = 13),
redundant study
population (n = 10), child
≤ 18 years of age not unit of
analysis (n = 8), did not
control for atopy (n = 30)
Studies met
selection
criteria
after contact
with authors
n = 38
Table 4. Descriptions of the eight studies and eight published papers that presented data on household
SHS exposure and incident asthma for the meta-analyses.
Reference Study Case doctor Cases/
(subgroup) location diagnosed referents RR 95% CI
Bergmann et al. 2000  Germany Yes 92/788 1.32 0.88–1.97
Jaakkola et al. 2001 (nap)  Norway Yes 80/1,571 0.84 0.53–1.34
Neuspiel et al. 1989  Britain No (wb) 590/8,760 1.49 1.18–1.87
Ponsonby et al. 2000  Australia No  88/205 1.09 0.94–1.26
Sigurs et al. 1995 Sweden Yes 12/128 1.2 0.41–3.60
Strachan et al. 1996  Britain No  2,665/11,906 1.10 0.76–1.60
Withers et al. 1998  Britain Yes 498/1,694 1.50 1.14–1.98
Zeiger and Heller 1995 (ap)  USA Yes 50/115 1.37 0.55–3.45
Abbreviations: ap, parents with atopy history; nap, parents with no atopy history; RR, relative risk estimate (not cor-
rected); wb, wheezy bronchitis; Yes/No, doctor-diagnosed asthma. confounding in individual studies, and exam-
ining the relationship between SHS exposure
and onset of childhood asthma. We have
evaluated and adjusted for additional sources
of heterogeneity among summary RR by
meta-regression methods and observed con-
sistent patterns of elevated RRs among stud-
ies. We observed a consistent, positive
association between household SHS exposure
and current, ever, and incident asthma. We
also observed an elevated summary RR for
incident asthma that was statistically signiﬁ-
cant among studies of schoolchildren with
postnatal exposure to SHS. We did not ﬁnd
that restricting exposure to postnatal SHS
was an important modiﬁer of summary RRs
for any of the asthma outcomes. Recent
reports by Cook and Strachan (1999) and the
U.S. DHHS (2006) have concluded that pre-
natal exposure to maternal smoking is not
necessary to elicit an adverse effect. Our
meta-regressions support this conclusion.
In our meta-regression of average house-
hold SHS exposure and ever asthma, covari-
ate control accounted for much of the
heterogeneity. The effect of not controlling
for family history of atopy reduced the RR
among ever asthma studies, and lack of con-
trol for both child and family history of
atopy reduced the estimate of RR among
incident asthma studies. These ﬁndings sug-
gest that this confounding variable biases the
estimate of RR toward the null.
Recent studies have identified elevated
levels of endotoxin in cigarette smoke and
SHS indoor spaces (Hasday et al. 1999;
Larsson et al. 2004). It is plausible that ele-
vated endotoxin exposure would cause ele-
vated immunoglobulin E levels in families
(including the child) exposed to SHS, and
thus affect the likelihood of atopy and subse-
quent asthma. However, we were unable to
analyze the relationship between exposed and
unexposed family members and their atopy
(and subsequent asthma) status separately
because we did not have individual-level data.
We observed that summary RRs from
studies that examined ever asthma among
younger children were slightly higher than
RRs from studies of exclusively older chil-
dren. These ﬁndings are contrary to the ﬁnd-
ings from cohort studies but consistent with
previous reviews (Cook and Strachan 1999;
Strachan and Cook 1998).
Most of the cross-sectional studies
assessed SHS exposure status by asking if
household or parental sources currently
smoked. One explanation of these ﬁndings is
that RRs from cross-sectional studies of older
children could be biased downward because
assessment of current SHS exposure status
may not reﬂect early-life exposure. For exam-
ple, parental smoking habits may change
once symptoms of allergy or asthma appear
in their children. If this occurred among
older asthmatics, then these children may be
classiﬁed as nonexposed, which would result
in a differential misclassiﬁcation of exposure
among cases. This source of bias is avoided
in prospective cohort study designs.
When studies did not restrict subjects to
nonsmoking children, summary RRs were
higher, possibly due to bias upward from
exposure among studies that overlooked this
source of SHS exposure. It is also possible that
study subjects who themselves are smokers are
more likely to have been exposed to higher
levels of household SHS (Wang et al. 1999).
Therefore, including smokers in the analysis
would increase the RR of developing asthma
among the study population. However, most
studies did not assess whether asthma devel-
oped among study subjects before taking up a
smoking habit of their own.
The RR for the average household SHS
exposure effect on ever asthma appeared
similar to the effect on current and incident
asthma, according to our meta-regression
analysis. The RR for prevalent asthma could
be slightly lower because of bias downward if
household exposure to SHS occurred up to
the time of asthma diagnosis and then
stopped. This would mean that asthmatics
with past but not current household SHS
might be misclassiﬁed as nonexposed.
Cook and Strachan (1999), Strachan and
Cook (1998), and the U.S. DHHS (2006)
observed a stronger RR for incident asthma or
wheezing illness among younger children
compared with their findings among older
children. These investigators suggested that
the stronger relationship with younger chil-
dren might be attributed to exacerbation of
intercurrent infection among young children,
resulting in transient wheeze that would tend
to diminish with age and increasing airway
caliber. This proposed mechanism would sug-
gest that SHS may not be a sole primary cause
of early childhood asthma; rather, it may be
one of several required co-factors that when
combined may lead to asthma development.
In our cohort study meta-regression, we
also found that much of the observed hetero-
geneity was accounted for by the age category
of children in the study. Most important,
older children exposed to SHS were more
Vork et al.
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Table 5. Summary estimates, 95% CIs and data descriptions for household SHS exposure comparisons
grouped by type of asthma.a
Type of combined Asthma type Percentile
estimate of RRb No. RR 95% CI p-Value Min 25th 75th Max
Current 
Uncorrected 15 1.30 1.22–1.39 0.249* 0.86 1.24 1.60 2.17
Correctedc 11 1.25 1.21–1.30 0.528 0.88 1.23 1.38 2.17
Ever 
All studiesc,d 23 1.48 1.32–1.65 <0.001* 0.57 1.45 1.74 5.81
Household SHS 17 1.51 1.31–1.75 <0.001* 0.94 1.47 1.73 5.81
Maternal smoking 6 1.29 1.15–1.45 0.190* 1.21 1.21 1.98 2.77
Incident 
All studies 8 1.21 1.08–1.36 0.225* 0.84 1.08 1.33 1.49
Household SHS 4 1.13 0.89–1.44 0.544 0.84 0.92 1.26 1.27
Maternal smoking 4 1.24 1.06–1.45 0.074* 1.08 1.08 1.45 1.49
Abbreviations: CI, confidence interval; Max, maximum value of the distribution; Min, minimum value of the distribution;
p-value, value from the p distribution for the null hypothesis that the rate ratio is constant across studies.
aWe report random effects estimates. bWe report corrected estimates unless otherwise indicated. cWe removed four
studies from the analysis of current asthma (Azizi et al. 1995; Daigler et al. 1991; Murray and Morrison 1990; Palmieri et al.
1990) and one study from the analysis of ever asthma (Pokharel et al. 2001) for lack of enough information to convert odds
ratios into estimates of RR. dExcluded six studies already included in the current asthma analysis. *Heterogeneity. 
Table 6. Summary estimates for household SHS exposure comparisons grouped by type of asthma cases
[ever (1 outlier excluded) versus incident asthma].a
Covariable inﬂuence on reference estimate of RR Combined RRsb 95% CI
Ever asthma modelc
Joint referenced (n = 22) 1.21 1.17–1.26
Not controlled for family atopy (n = 12) 1.02 0.90–1.16
Not adjusted for child’s own smoking (n = 12) 1.63 1.54–1.73
Includes subjects < 6 years of age (n = 5) 1.45 1.39–1.52
Incident asthma modele
Joint referencef (n = 8) 1.33 1.14–1.56
Not controlled for child atopy (n = 3) 1.09 0.93–1.28
All study subjects < 6 years of age (n = 2)  1.05 0.94–1.16
RR, corrected estimate of relative risk. 
aWe report ﬁxed-effects estimates; the log rate ratio regressed on the set of covariates listed in the table for each meta-
regression. bRatio of corrected relative risk estimates are comparing studies/strata in the designated index category with
studies/strata in the reference category of that covariate. cResidual homogeneity, p = 0.85. dEver asthma model reference
category = studies that included only older children, controlled for child’s own smoking, and controlled for family atopy.
eResidual homogeneity, p = 0.82. fIncident asthma model reference category = only older children and controlled for
child atopy. likely than younger children to develop
asthma. We found no evidence that RRs
from studies using physician diagnosis to
identify cases were systematically different
than RRs from studies that did not identify
cases in this way. The differences in our
meta-analysis findings versus earlier studies
are likely attributed to differences in
approach and the inclusion of studies in our
meta-analysis published after the previous
meta-analyses. We looked more precisely at
the relationship between SHS exposure and
asthma as distinct from wheeze alone, and we
restricted our analysis to studies that con-
trolled for atopy history. Thus our meta-
analysis examines a subtly different question
than earlier meta-analyses (Cook and
Strachan 1999; Strachan and Cook 1998),
and takes advantage of the increased body of
epidemiologic literature.
Because cohort studies classify subjects
by exposure at the start of follow-up, it is less
likely that exposure misclassification would
occur and more likely that the child’s age is a
reasonable surrogate measure of the length of
time study subjects are exposed to household
SHS. This positive relationship between a
surrogate of duration of household SHS
exposure and RR was also observed within
individual studies (Neuspiel et al. 1989;
Wolf-Ostermann et al. 1995). Hence, a ﬁnd-
ing that higher summary RRs occurred in
studies of older children suggests that SHS
exposure duration may also play a funda-
mental role in the development of asthma.
The positive relationship with age cate-
gory identiﬁed in these studies suggests that
the risk of developing asthma from a longer
time of exposure to SHS increases in later
childhood. The RRs among studies that
examined incident asthma were more posi-
tively associated with SHS exposure than
were studies of prevalent asthma. The ele-
vated RRs for the association between house-
hold SHS and prevalent as well as incident
asthma suggest that the association between
SHS exposure and asthma is not caused by
selection or misclassiﬁcation biases.
A mechanistic theory consistent with our
findings holds that the development of
asthma can be causally associated with the
chronic effects from exposure to SHS on
bronchial hyperreactivity rather than the
acute effects of SHS exposure on airway cal-
iber (Halken et al. 1995; U.S. EPA 1992).
Others have also recently drawn this conclu-
sion [“postnatal exposure shows a causal link
with the development of asthma in child-
hood” (Gilmour et al. 2006); and “strong
evidence also supports a causal role of envi-
ronmental tobacco smoke in childhood
asthma, especially in the induction of
asthma, but also in the poor overall control
of an established disease” Jaakkola and
Jaakkola 2002)]. The question of asthma
incidence increasing with age and duration
of exposure is important because if RR
increases with age and duration of exposure,
it becomes less likely that asthma from SHS
exposure early in life is attributed solely to a
transient vulnerability in early childhood
that is less likely to result in enduring dis-
ease. It also means that public health inter-
ventions to stop childhood SHS exposure
may have a positive benefit in preventing
asthma induction beyond early childhood.
Conclusions
Clearer understanding of the role of SHS in
childhood asthma induction can help inform
public health interventions to prevent child-
hood SHS exposure and the benefits from
such interventions. Our analysis attempted to
address some of the remaining concerns
posed by previous reviewers who stated that
the evidence for an association between
household SHS exposure and new-onset
asthma is equivocal especially among older
children. We observed a positive and consis-
tent pattern of association between household
SHS exposure and the RR of developing
asthma during childhood in our meta-analy-
ses. In contrast to earlier ﬁndings, this associ-
ation was not limited to younger children,
certain high-risk populations, or prevalent
cases. Similar to previous analyses, we did not
ﬁnd that prenatal exposure to SHS was neces-
sary to observe elevated summary RRs for any
of the asthma outcomes.
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